Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Boehringer Ingelheim
Chubb
McKinsey
Merck
Citi
Argus Health
Covington

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,736,665

« Back to Dashboard

Which drugs does patent 7,736,665 protect, and when does it expire?

Patent 7,736,665 protects PROBUPHINE and is included in one NDA.

This patent has ten patent family members in seven countries.
Summary for Patent: 7,736,665
Title:Implantable polymeric device for sustained release of buprenorphine
Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
Inventor(s): Patel; Rajesh A. (Redwood City, CA), Bucalo; Louis R. (Miami Beach, FL)
Assignee: Titan Pharmaceuticals, Inc. (South San Francisco, CA)
Application Number:10/453,377
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 7,736,665

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Braeburn Pharms Inc PROBUPHINE buprenorphine hydrochloride IMPLANT;IMPLANTATION 204442-001 May 26, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up FOR OPIOID DEPENDENCE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,736,665

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003240493 ➤ Sign Up
Australia 2008212011 ➤ Sign Up
Canada 2487577 ➤ Sign Up
European Patent Office 1509182 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKinsey
Cerilliant
Julphar
Deloitte
US Army
Teva
US Department of Justice
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.